WuXi Congratulates TaiMed Biologics On Receiving Orphan Drug Designation For Ibalizumab From U.S. FDA
October 23, 2014 at 16:32 PM EDT
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with ...